United Therapeutics enters $477.6M accelerated share repurchase with Citi
United Therapeutics entered an accelerated share repurchase agreement with Citi to repurchase about $477.6 million of common stock under its existing buyback program. It will make an upfront payment around Sep 10, 2026.
6 million of its common stock under its existing buyback program. 6 million around Sep 10, 2026 and receive an initial deliver…